Morning Blue Light Therapy for TBI, Alzheimer’s, Parkinson’s, and Glymphatic Drainage in ME/CFS and Long Haul. Methylene Blue Implications.

Morning Blue Light Therapy has long standing notable published research that it helps TBI patients improve, and more recently Alzheimer’s patients improve cognitive function, while also activating brain circuits associated with Glymphatic Drainage by modulating Aquaporin-4.